Table 2.

Predictors of improved flow-mediated dilation at multivariable stepwise regression analysis

	b	Std. Err	p-value
Baseline flow-mediated dilation levels	− 0.15	0.04	0.0034
Use of SGLT2 inhibitors	1.33	0.34	0.0009
Change in glycated hemoglobin levels	− 7.30	2.70	0.0140
Change in C-reactive protein levels	0.76	0.34	0.0373
Baseline C-reactive protein levels	− 0.16	0.07	0.0447